Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ishita Drugs & Industries is an Indian pharmaceutical company primarily engaged in the manufacture and export of Active Pharmaceutical Ingredients (APIs) and drug intermediates. Established in 1992 and based in Ahmedabad, the company specializes in therapeutic segments such as anti-fungals, anti-protozoals, and anti-bacterials. Their core product portfolio includes widely used compounds like Fluconazole, Terbinafine HCl, Ornidazole, and Tinidazole. The company operates GMP-compliant manufacturing facilities and serves a global client base across various regulated and semi-regulated markets. Ishita Drugs & Industries is publicly traded on the Bombay Stock Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ishita Drugs & Industries.